Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

BACKGROUND: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of metform...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharakhani, Mohsen, Neghab, Nosrat, Farimani, Marzie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://www.ncbi.nlm.nih.gov/pubmed/24963365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059955/
https://www.ncbi.nlm.nih.gov/pubmed/24963365

Ejemplares similares